MedTrace Logo

Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study

NCT00466778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2007-09-21

No results posted yet for this study

Summary

This is a case-controlled study using an innovative, non-invasive, FDA approved technology to measure the autonomic nervous system. Detection of unsuspected DPN or ANS dysfunction may allow physicians to re-assess current treatment and develop new dietary or pharmacological strategies. This also is an immense public health concern since there are currently 18 million diabetics in the United States and 220 million worldwide.

Conditions

Sponsors & Collaborators

  • Weintraub, Michael I., MD, FACP, FAAN

    lead INDIV

Principal Investigators

  • Richard A. Noto, MD · Phelps Memorial Hospital

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00466778 on ClinicalTrials.gov